Company news
Entera Bio Ltd. news in 2021
Entera Bio Ltd.'s news releases, calls and decks from 2021, newest first.
Entera Bio Reports Third Quarter 2021 Financial Results
November 9, 2021
Entera Bio Publishes Key Study Describing its Oral Delivery Technology Platform for Biologic Drugs
October 27, 2021
Entera Bio Presents Positive Phase 2 6-Month Bone Mineral Density Data for Oral PTH Formulation at Late Breaker ASBMR Conference Session
October 5, 2021
Entera Bio Selected for Late Breaking Oral Presentation of Phase 2 6-Month Osteoporosis Data at ASBMR 2021 Annual Meeting
August 31, 2021
Entera Bio to Present at H.C. Wainwright 23rd Annual Global Investment Conference
August 22, 2021
Entera Bio to Conduct Annual Shareholders Meeting on October 4, 2021
August 22, 2021
Entera Bio Reports Second Quarter 2021 Financial Results and Provides Clinical Updates
August 15, 2021
Entera Bio to Report Business and Financial Results for the Quarter ended June 30, 2021, on August 16, 2021
August 12, 2021
Entera Bio to Present Phase 2 EB613 Oral PTH Osteoporosis Treatment 3-Month Findings at the American Society for Bone and Mineral Research Annual Meeting
August 1, 2021
Entera Bio to Conduct Conference Call on June 30 to Discuss Phase 2 Results for EB613 Positioned to be the First Oral Bone-Building Agent for the Treatment of Osteoporosis
June 27, 2021
Entera Bio Announces Excellent Topline Phase 2 BMD Data for EB613, the Study Met Its Primary and Key Secondary Endpoints
June 22, 2021
Entera Bio Receives Foundational Patent for its Oral PTH using its Platform Oral Protein Delivery Technology in European Union
June 16, 2021
Entera Bio Reports First Quarter 2021 Financial Results and Provides Clinical Updates
May 19, 2021
Entera Announces Ron Mayron, a Global Pharma Leader, Joins its Board of Directors
April 19, 2021
Entera Appoints Ramesh Ratan as Chief Financial Officer
April 14, 2021
New Data Suggest Entera’s Platform Orally Delivers Human Growth Hormone, Study Results to be Presented at European Pharma Congress
April 5, 2021
Entera Bio Ltd Announces Operating and Financial Results for the Fourth Quarter and Year Ended December 31, 2020
March 17, 2021
Entera Bio to Report Financial Results for the Year Ended December 31, 2020 on March 18, 2021
March 10, 2021
Entera Bio Ltd Announces Positive Topline EB613 Phase 2 Biomarker Data
March 10, 2021
Entera Bio To Present At The H.C. Wainwright Global Life Sciences Conference
March 3, 2021
Entera Bio Announces Publication of Phase 2 Hypoparathyroidism Study in the Journal of Bone and Mineral Research
February 24, 2021
Entera Bio Initiates New Research Program For Oral GLP-2
February 7, 2021
Calls in 2021
Decks in 2021
- Technical Presentation (2021)
Technical · 15 slides · 2021